14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
2019-10-29 $1.76 $1.76 $1.51 $1.64 253 677
2019-10-28 $1.70 $1.79 $1.67 $1.72 253 260
2019-10-25 $1.76 $1.76 $1.66 $1.70 115 877
2019-10-24 $1.78 $1.83 $1.74 $1.77 205 637
2019-10-23 $1.73 $1.92 $1.73 $1.78 238 485
2019-10-22 $1.78 $1.78 $1.71 $1.74 73 792
2019-10-21 $1.90 $1.94 $1.71 $1.81 112 935
2019-10-18 $1.94 $1.95 $1.86 $1.90 42 276
2019-10-17 $1.96 $1.99 $1.91 $1.93 74 962
2019-10-16 $1.94 $1.97 $1.85 $1.97 97 641
2019-10-15 $2.02 $2.02 $1.85 $1.91 163 051
2019-10-14 $2.25 $2.28 $1.92 $2.02 384 514
2019-10-11 $2.65 $2.72 $2.12 $2.19 840 133
2019-10-10 $2.55 $2.65 $2.55 $2.60 35 488
2019-10-09 $2.60 $2.75 $2.52 $2.56 210 867
2019-10-08 $2.52 $2.62 $2.52 $2.57 12 984
2019-10-07 $2.59 $2.59 $2.50 $2.55 36 202
2019-10-04 $2.55 $2.64 $2.46 $2.62 102 435
2019-10-03 $2.57 $2.68 $2.46 $2.52 126 136
2019-10-02 $2.66 $2.75 $2.51 $2.66 110 494
2019-10-01 $2.74 $2.98 $2.69 $2.69 35 005
2019-09-30 $2.74 $2.83 $2.66 $2.75 80 413
2019-09-27 $2.74 $2.79 $2.65 $2.78 35 091
2019-09-26 $2.89 $2.92 $2.74 $2.74 81 050
2019-09-25 $2.88 $2.94 $2.81 $2.87 95 223
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT